0001123292-15-001128.txt : 20150821
0001123292-15-001128.hdr.sgml : 20150821
20150821192422
ACCESSION NUMBER: 0001123292-15-001128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150820
FILED AS OF DATE: 20150821
DATE AS OF CHANGE: 20150821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knickerbocker Aron Marc
CENTRAL INDEX KEY: 0001578766
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 151069731
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-20
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001578766
Knickerbocker Aron Marc
C/O FIVE PRIME THERAPEUTICS, INC.
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
EVP & Chief Business Officer
Common Stock
2015-08-20
4
A
0
75000
0
A
179965
D
Represents shares of restricted stock, which will vest according to the following schedule: 50% of the restricted stock vests on September 1, 2016 with the remainder vesting on March 1, 2017, provided the reporting person remains employed by the company through each such date.
Reflects the acquisition of 1,576 shares on May 15, 2015 pursuant to the Five Prime Therapeutics, Inc. 2013 Employee Stock Purchase Plan.
/s/ Francis Sarena, Attorney-in-Fact
2015-08-21